Abhishek ("Shake") Kumar, MD MAS
@ShakeKumarMD
Followers
749
Following
7K
Media
136
Statuses
2K
Radiation Oncology Chief Resident @DukeRadOnc | @ARRO_org Executive Committee Vice-Chair
Durham, NC
Joined November 2009
SO special to hear Coach K @DukeMBB give us radiation oncologists @DukeRadOnc a personal, real talk about leadership, teamwork, & culture. As a Duke undergrad & physician, I was very hyped to meet & talk with him at length. What a legend! 17-year-old me wouldn’t believe this
8
11
140
RT @chr_huang: New year new PGY2s!! 💙 Let's be awesome educators and promote a supportive work environment. We all have the same goals: gre….
0
4
0
RT @ElliotServaisMD: AIM-HIGH trial published in Lancet.Molecular high-risk stage IA-IIA NSCLC as determined by 14-gene assay with improved….
0
48
0
RT @DukeRadOnc: Duke #RadOnc is so proud of our graduating residents. Thank you to Drs. Acklin-Wehnert, Gooding, Kumar and Leng for their c….
0
2
0
RT @jonas_willmann: ❓ESTRO & EORTC proposed a classification to standardize reirradiation. But does it predict outcomes or toxicity?. 🫁☢️ W….
0
15
0
RT @SuyogCancer: 🌍📚 Calling the global oncology community!.We've launched a WhatsApp Academic Group to share:.🔹 Key trial data.🔹 Conference….
0
16
0
RT @NicholasZaorsky: My 2025 ASTRO GU #radonc spring refresher presentation (+ hidden slides) is available online.#….
0
43
0
RT @DrewMoghanaki: From my perspective, this UPMC phase II study for H&N cancers is a landmark randomized clinical trial, even though it en….
0
7
0
0
2
0
RT @VedangMurthy: During residency, when modems crackled and PubMed barely loaded, I relied on Sem in Rad Oncol for the latest info. Contr….
0
12
0
RT @MikkaelSekeres: Announcing the first EVER @JCO_ASCO Art of Oncology Narrative Medicine Contest! 🎉✍️🎗️🩺🎉.We're looking for essays that e….
0
32
0
RT @VedangMurthy: @jryckman3 @davcmed @DrAndrewLoblaw @cristian_udo @krishnan_patel Looks like we beat you to it Drew! 😀.PSMA-PET, MRI, DIL….
0
5
0
RT @DrAndrewLoblaw: I stand corrected! Well done @VedangMurthy . I’m so glad we have the same questions and drive to answer those question….
0
2
0
RT @CJTsaiMDPhD: @DrewMoghanaki @_ShankarSiva @TROGfightcancer This is great and much needed. Congrats on getting this through and funded!.
0
1
0
RT @Erman_Akkus: Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, mul….
0
43
0
RT @Sushilberiwal: Finally one positive data on breast cancer for oligoprogression. Focused only on HR positive breast cancer unlike previo….
0
6
0
RT @ZeidanMd: 🔥NSABP- B51 is out!.Practice changing trial supporting RT de-escalation in cN1, ypN0 breast cancer. 👉longer follow up desired….
0
50
0
RT @DrAndrewLoblaw: EXTEND showed us that MDT + ADT > ADT.RADIOSA showed MDT + ADT > MDT. STORM / PEACE-V showed ENI + MDT + ADT > MDT + A….
0
22
0